Your partner in computational drug design
Silicos-it is a Belgian consultancy company, founded in 2010 and specialised in computational drug design. We provide support in all aspects of modern computational drug design, including virtual screening, molecular dynamics applications, and state-of-the-art structure-activity machine learning models. In addition, we are also involved in writing open source software tools.
Since 2013, a strong relation with the University of Antwerp (UA) was established. Because of this, we can provide you with a complete set of solutions to all your questions related to computational drug design. This may include service work under the wings of the UA, submission and execution of a VLAIO project with the UA as academic partner, or some well-defined fee-for-service projects with Silicos-it as the commercial partner.
Do you like to find out more of what we can do for you? Then have a look at the research examples page on this website for ideas and opportunities. And the who are we page gives you insight into our history and where we are right now.
Do you think we can help you? We are open to many forms of collaboration. Therefore, do not hesitate to contact us to discuss your potential research ideas. Maybe it is the beginning of a mind-blowing research collaboration!
Our latest post
-
Small-molecule-induced ERBB4 activation to treat heart failure
A paper in which we contributed just came out in Nature Communications. This paper presents exciting research on a potential new treatment for heart failure, a serious condition affecting many people. In this project, small molecules were discovered that can activate a protein called ERBB4, helping heart cells protect from damage. One particular compound, named EF-1, showed impressive results in reducing heart damage and fibrosis in experiments. A key part of the study involved using machine learning to analyze a vast library of compounds, helping to identify the most promising candidates for further testing.